VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis: Amsterdam Wednesday, February 11, 202 ...

US FDA accepts and grants priority review status to Takeda’s oveporexton for the treatment of narcolepsy type 1: Osaka, Japan Wednesday, February 11, 2026, 12:00 Hrs [IST] Taked ...

Chugai Pharma and Araris Biotech ink license agreement for Araris' linker-payload ADC technology AraLinQ: Tokyo Wednesday, February 11, 2026, 11:00 Hrs [IST] Chugai Pharmaceutical ...

Dr Bruce Levine to receive the Genome Valley Excellence Award at Bio Asia 2026: Our Bureau, Mumbai Tuesday, February 10, 2026 ...

GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older: London, UK Wednesday, February 11, 2026, 09:00 Hrs [IST] GSK plc announced ...

Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia: Paris Wednesday, February 11, 2026, ...

Pharmexcil to hold Chintan Shivir on long-term strategic roadmap for pharma industry on Feb 21 in Ahmedabad: Shardul Nautiyal, Mumbai Wednesday, February 11, 2026, 08:00 Hrs [IST] ...

DGFT extends deadline for filing Annual RoDTEP Return till March 31, 2026: Shardul Nautiyal, Mumbai Wednesday, February 11, 2026, 08:00 Hrs [IST] The Directorate General of Foreig ...

The Environment Ministry’s decision to allow a few traders to import preowned medical equipment is in direct conflict with the earlier National Policy decisions whether from preventing India to be a ...

Nandita Vijayasimha, Bengaluru Wednesday, February 11, 2026, 08:00 Hrs [IST] ...

At the manufacturing level, pharmaceutical manufacturers are leveraging advanced technologies and automation to address challenges such as sample under fill and overfill, detect contaminants and other ...

The Ministry of Ayush has received a 10.4% higher allocation in the Budget Estimates (BE) of the Union Budget 2026-27, as compared to the BE for the previous fiscal year, with higher allocation for ...